Tenax Therapeutics TENX
NASDAQ TENX
$1.98 +0.05 (+2.59%)
At close: Oct 2, 2026 · 4:00 PM EDT

Tenax Therapeutics (TENX) Gains from Sales and Divestitures (2014 - 2023)

Updated

Tenax Therapeutics (TENX) posted Gains from Sales and Divestitures of $125.00 for Q4 2023, down 95.7% from $2,901 a year earlier.

Analysis

Tenax Therapeutics (TENX) Gains from Sales and Divestitures (2014 - 2023) Analysis & Trends

For FY2023, Tenax Therapeutics' Gains from Sales and Divestitures came in at -$1,000.

  • In prior years, Tenax Therapeutics' Gains from Sales and Divestitures was $2,901 in FY2022 and -$522.00 in FY2019.
  • Quarterly Gains from Sales and Divestitures has run from a low of -$4,896 in Q2 2023 to a high of $3,771 in Q1 2023 over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Tenax Therapeutics 89.55 Mn 89.55 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 125.00
Jun 30, 2023 -4,896.00
Mar 31, 2023 3,771.00
Dec 31, 2022 2,901.00
Mar 31, 2019 -522.00
Dec 31, 2017 -76.00
Dec 31, 2015 450.00
Apr 30, 2014 -2,519.00
API Access

Tenax Therapeutics Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=TENX&period=max&api_key=YOUR_API_KEY